Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Generic Industry Not Sold On Benefits Of FDA Emerging Technology Program
Nov 19 2019
•
By
Joanne S. Eglovitch
Generic Industry Presses FDA For More Incentives To Participate In Emerging Technology Program • Source: Shutterstock
More from Manufacturing
More from Compliance